QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
Lowest-Rated StocksLowest-Rated
NASDAQ:DOCS

Doximity (DOCS) Stock Forecast, Price & News

$32.65
-1.41 (-4.14%)
(As of 06/7/2023 ET)
Compare
Today's Range
$32.65
▼
$34.97
50-Day Range
$30.61
▼
$36.75
52-Week Range
$22.91
▼
$47.46
Volume
1.61 million shs
Average Volume
1.63 million shs
Market Capitalization
$6.36 billion
P/E Ratio
62.79
Dividend Yield
N/A
Price Target
$36.82
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media

Doximity MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
12.8% Upside
$36.82 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.47mentions of Doximity in the last 14 days
Based on 18 Articles This Week
Insider Trading
Selling Shares
$262,500 Sold Last Quarter
Proj. Earnings Growth
23.08%
From $0.65 to $0.80 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.26 out of 5 stars

Medical Sector

258th out of 981 stocks

Custom Computer Programming Services Industry

10th out of 26 stocks

See Top Rated MarketRank™ Stocks Here

DOCS stock logo

About Doximity (NASDAQ:DOCS) Stock

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Receive DOCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Doximity and its competitors with MarketBeat's FREE daily newsletter.

DOCS Stock News Headlines

May 23, 2023 | marketbeat.com
Doximity is an Overlooked Medical Ecosystem AI Play
Doximity Inc. (NASDAQ: DOCS) is a digital professional social network platform for medical practitioners. It’s a medical community networking platform like
June 7, 2023 | msn.com
Needham Reiterates Doximity Inc - (DOCS) Prior Recommendation
June 7, 2023 | Vantage Point (Ad)
Stop Trading Like A Turtle
Performing at your best requires quick reaction and adaptability. While slow and steady progress works for some, having a tool that enables informed trading decisions is essential amid volatility. It's 2023. Why trade like a turtle when you could track down new opportunities like a cheetah?
June 7, 2023 | markets.businessinsider.com
Doximity (DOCS) Receives a Buy from Canaccord Genuity
June 7, 2023 | msn.com
Doximity Aims for $1B Topline In 2028
June 7, 2023 | americanbankingnews.com
Stock Traders Buy High Volume of Doximity Call Options (NASDAQ:DOCS)
June 6, 2023 | msn.com
3 Top Healthcare Stocks to Buy for June
June 5, 2023 | msn.com
The Latest Analyst Ratings for Doximity
June 7, 2023 | Behind the Markets (Ad)
AI Creates New Cancer Drug - In Just 30 Days!
On December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... There's one small-cap at the center of it all. Bill Gates owns 7 million shares... Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares...
June 5, 2023 | msn.com
Truist Securities Maintains Doximity Inc - (DOCS) Hold Recommendation
June 5, 2023 | americanbankingnews.com
Doximity (NASDAQ:DOCS) Price Target Lowered to $33.00 at Truist Financial
June 4, 2023 | americanbankingnews.com
Doximity, Inc. (NASDAQ:DOCS) Receives $35.80 Average PT from Brokerages
May 28, 2023 | finance.yahoo.com
1 No-Brainer Stock to Buy With $100 Right Now
May 26, 2023 | finance.yahoo.com
Doximity (DOCS) Reports Q4 Earnings: What Key Metrics Have to Say
May 23, 2023 | americanbankingnews.com
Head-To-Head Contrast: Doximity (NASDAQ:DOCS) & Symbolic Logic (NASDAQ:EVOL)
May 21, 2023 | americanbankingnews.com
Doximity (NASDAQ:DOCS) PT Lowered to $32.00
May 19, 2023 | msn.com
Morgan Stanley Maintains Doximity Inc - (DOCS) Underweight Recommendation
May 19, 2023 | americanbankingnews.com
Doximity (NASDAQ:DOCS) Shares Gap Down on Analyst Downgrade
May 18, 2023 | msn.com
Evercore ISI Group Maintains Doximity Inc - (DOCS) In-Line Recommendation
May 18, 2023 | msn.com
Needham Reiterates Doximity Inc - (DOCS) Buy Recommendation
May 17, 2023 | bloomberg.com
Target, Energy, Debt Ceiling, and Doximity
May 17, 2023 | msn.com
Why Doximity Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 17, 2023 | theglobeandmail.com
Why Doximity (DOCS) Shares Are Sliding Today
May 17, 2023 | markets.businessinsider.com
Needham Keeps Their Buy Rating on Doximity (DOCS)
May 17, 2023 | msn.com
What's Going On With Doximity Stock Wednesday?
May 17, 2023 | markets.businessinsider.com
Doximity (DOCS) Receives a Hold from Wells Fargo
May 17, 2023 | seekingalpha.com
Doximity Q4 Earnings: Large Miss In Guidance
See More Headlines

DOCS Price History

DOCS Company Calendar

Last Earnings
5/16/2023
Today
6/07/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
3/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Custom computer programming services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:DOCS
CUSIP
N/A
CIK
1516513
Web
www.doximity.com
Phone
650-549-4330
Fax
N/A
Employees
850
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$36.82
High Stock Price Forecast
$49.00
Low Stock Price Forecast
$29.00
Forecasted Upside/Downside
+7.5%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
10 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$0.52
Trailing P/E Ratio
65.88
Forward P/E Ratio
52.71
P/E Growth
11.35
Net Income
$112.82 million
Net Margins
26.92%
Pretax Margin
31.78%
Return on Equity
12.74%
Return on Assets
10.94%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.99
Quick Ratio
6.99

Sales & Book Value

Annual Sales
$419.05 million
Price / Sales
15.92
Cash Flow
$0.72 per share
Price / Cash Flow
47.27
Book Value
$4.98 per share
Price / Book
6.88

Miscellaneous

Outstanding Shares
194,670,000
Free Float
106,658,000
Market Cap
$6.67 billion
Optionable
Not Optionable
Beta
0.86

Key Executives

  • Mr. Jeffrey A. Tangney (Age 49)
    Co-Founder, CEO & Chairperson
    Comp: $243.39k
  • Ms. Anna BrysonMs. Anna Bryson (Age 32)
    Chief Financial Officer
    Comp: $403.21k
  • Mr. Paul JorgensenMr. Paul Jorgensen (Age 52)
    Chief Revenue Officer
    Comp: $647.99k
  • Dr. Nate Gross M.D.
    Co-Founder & Chief Strategy Officer
  • Ms. Shari Buck
    Co-founder and SVP People & Ops
  • Mr. Jey Balachandran
    Chief Technology Officer
  • Mr. Perry Scott Gold
    Head of Investor Relations
  • Ms. Jennifer W. Chaloemtiarana (Age 54)
    Gen. Counsel & Corp. Sec.
  • Jim Rivas
    Head of Corp. Communications
  • Mr. Bruno Miranda
    Sr. VP of Engineering

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













DOCS Stock - Frequently Asked Questions

Should I buy or sell Doximity stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Doximity in the last year. There are currently 3 sell ratings, 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" DOCS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DOCS, but not buy additional shares or sell existing shares.
View DOCS analyst ratings or view top-rated stocks.

What is Doximity's stock price forecast for 2023?

10 equities research analysts have issued 1 year target prices for Doximity's shares. Their DOCS share price forecasts range from $29.00 to $49.00. On average, they anticipate the company's stock price to reach $36.82 in the next twelve months. This suggests a possible upside of 7.5% from the stock's current price.
View analysts price targets for DOCS or view top-rated stocks among Wall Street analysts.

How have DOCS shares performed in 2023?

Doximity's stock was trading at $33.56 at the beginning of the year. Since then, DOCS stock has increased by 2.1% and is now trading at $34.26.
View the best growth stocks for 2023 here.

When is Doximity's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our DOCS earnings forecast.

How were Doximity's earnings last quarter?

Doximity, Inc. (NASDAQ:DOCS) announced its quarterly earnings results on Tuesday, May, 16th. The company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.02. The business earned $110.97 million during the quarter, compared to analyst estimates of $110.11 million. Doximity had a net margin of 26.92% and a trailing twelve-month return on equity of 12.74%.

What ETFs hold Doximity's stock?

ETFs with the largest weight of Doximity (NASDAQ:DOCS) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Jacob Forward ETF (JFWD), Janus Henderson Small Cap Growth Alpha ETF (JSML), Fidelity Digital Health ETF (FDHT), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Harbor Corporate Culture Leaders ETF (HAPY).Renaissance IPO ETF (IPO).

What guidance has Doximity issued on next quarter's earnings?

Doximity issued an update on its first quarter 2024 earnings guidance on Friday, May, 26th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $106.50 million-$107.50 million, compared to the consensus revenue estimate of $112.09 million.

When did Doximity IPO?

(DOCS) raised $501 million in an initial public offering on Thursday, June 24th 2021. The company issued 23,300,000 shares at a price of $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities acted as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers.

What is Doximity's stock symbol?

Doximity trades on the NASDAQ under the ticker symbol "DOCS."

Who are Doximity's major shareholders?

Doximity's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Clearbridge Investments LLC (3.50%), BlackRock Inc. (2.82%), FMR LLC (2.71%), Baillie Gifford & Co. (2.27%), Price T Rowe Associates Inc. MD (1.22%) and Credit Suisse AG (1.07%). Insiders that own company stock include Anna Bryson, Gilbert H Kliman, Interwest Partners X Lp, Joseph B Kleine, Kevin Spain, Kira Scherer Wampler, Paul W Jorgensen and Timothy S Cabral.
View institutional ownership trends.

How do I buy shares of Doximity?

Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Doximity's stock price today?

One share of DOCS stock can currently be purchased for approximately $34.26.

How much money does Doximity make?

Doximity (NASDAQ:DOCS) has a market capitalization of $6.67 billion and generates $419.05 million in revenue each year. The company earns $112.82 million in net income (profit) each year or $0.52 on an earnings per share basis.

How many employees does Doximity have?

The company employs 850 workers across the globe.

How can I contact Doximity?

The official website for the company is www.doximity.com. The company can be reached via phone at 650-549-4330 or via email at ir@doximity.com.

This page (NASDAQ:DOCS) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -